CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Apr 01, 2024 | Option Exercise | $22.92 | 100,000 | 2,291,640 | 65,638 | Apr 03, 2024, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Mar 04, 2024 | Option Exercise | $22.26 | 100,000 | 2,225,550 | 65,638 | Mar 06, 2024, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Feb 29, 2024 | Option Exercise | $22.33 | 100,000 | 2,232,890 | 65,638 | Mar 04, 2024, 05:49 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Feb 07, 2024 | Sale | $41.54 | 2,161 | 89,777 | 6,370 | Feb 08, 2024, 07:19 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Feb 07, 2024 | Sale | $41.54 | 2,506 | 104,110 | 15,638 | Feb 08, 2024, 07:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Tregoning Kathleen | See Remarks | Dec 26, 2023 | Option Exercise | $10.05 | 3,150 | 31,658 | 10,666 | Dec 28, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Option Exercise | $22.99 | 20,000 | 459,700 | 24,673 | Dec 28, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Sale | $22.48 | 16,000 | 359,608 | 32,663 | Dec 27, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Bodenrader Mark | See Remarks | Dec 20, 2023 | Sale | $41.42 | 7,889 | 326,788 | 17,724 | Dec 21, 2023, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | DiPietro Kenneth | Chief Human Resources Officer | Dec 20, 2023 | Sale | $41.42 | 6,256 | 259,144 | 24,663 | Dec 21, 2023, 08:24 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Akamine Scott | Chief Legal Officer | Dec 20, 2023 | Sale | $41.42 | 7,072 | 292,945 | 7,237 | Dec 21, 2023, 08:21 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro | Chief Medical Officer | Dec 20, 2023 | Sale | $41.42 | 10,152 | 420,528 | 14,673 | Dec 21, 2023, 08:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | ALTSCHULLER Susan | Chief Financial Officer | Dec 20, 2023 | Sale | $41.42 | 13,808 | 571,972 | 16,913 | Dec 21, 2023, 08:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Tregoning Kathleen | See Remarks | Dec 20, 2023 | Sale | $41.42 | 6,288 | 260,469 | 7,516 | Dec 21, 2023, 08:10 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Option Exercise | $25.63 | 15,000 | 384,493 | 7,500 | Dec 19, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Option Exercise | $22.43 | 20,000 | 448,700 | 10,000 | Dec 11, 2023, 04:17 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Option Exercise | $27.27 | 20,000 | 545,400 | 10,513 | Dec 07, 2023, 07:45 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Option Exercise | $24.09 | 15,000 | 361,275 | 8,013 | Dec 07, 2023, 07:45 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 14, 2023 | Option Exercise | $14.31 | 45,648 | 653,339 | 25,528 | Nov 16, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 07, 2023 | Sale | $14.26 | 54,152 | 772,321 | 29,780 | Nov 09, 2023, 05:03 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 08, 2023 | Sale | $14.33 | 200 | 2,866 | 2,804 | Nov 09, 2023, 05:03 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 03, 2023 | Sale | $14.47 | 122,802 | 1,776,362 | 64,105 | Nov 06, 2023, 05:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 02, 2023 | Sale | $14.34 | 77,198 | 1,107,336 | 41,303 | Nov 06, 2023, 05:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | PATRICK DEVAL L | Director | Nov 01, 2023 | Sale | $18.81 | 60,260 | 1,133,491 | 33,412 | Nov 03, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Gordon Christopher R | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Koppel Adam | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Bain Capital Partners XII, LLC | 10% Owner | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH | Director | Oct 16, 2023 | Buy | $22.81 | 876,808 | 19,999,990 | 10,794,876 | Oct 17, 2023, 04:53 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Sep 07, 2023 | Option Exercise | $13.78 | 100,000 | 1,378,415 | 52,704 | Sep 08, 2023, 04:35 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renaud Ronald C JR | President & CEO | Aug 03, 2023 | Buy | $23.96 | 83,857 | 2,008,811 | 83,857 | Aug 07, 2023, 05:13 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Burgess Paul D. | See Remarks | Aug 04, 2023 | Buy | $22.93 | 21,880 | 501,794 | 21,880 | Aug 07, 2023, 05:11 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Jul 11, 2023 | Option Exercise | $16.76 | 100,000 | 1,676,340 | 52,704 | Jul 13, 2023, 05:41 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | DEKKERS MARIJN E | Director | Jun 15, 2023 | Sale | $34.43 | 200,000 | 6,886,000 | 402,326 | Jun 20, 2023, 04:56 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Option Exercise | $18.05 | 100,000 | 1,805,070 | 52,704 | Jun 05, 2023, 08:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Bodenrader Mark | See Remarks | Jun 02, 2023 | Sale | $32.95 | 1,895 | 62,440 | 5,522 | Jun 05, 2023, 08:07 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Sale | $17.48 | 100,000 | 1,748,434 | 52,704 | May 08, 2023, 04:24 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Option Exercise | $14.28 | 100,000 | 1,428,130 | 52,704 | Apr 13, 2023, 04:48 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Sale | $15.35 | 6,000 | 92,070 | 5,704 | Mar 06, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Sale | $15.31 | 94,000 | 1,438,877 | 49,704 | Mar 06, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Sale | $18.31 | 100,000 | 1,831,401 | 52,704 | Feb 08, 2023, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Sale | $16.72 | 100,000 | 1,671,871 | 52,704 | Jan 06, 2023, 05:04 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Sale | $15.08 | 100,000 | 1,508,300 | 52,704 | Dec 13, 2022, 04:44 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Nov 01, 2022 | Option Exercise | $18.78 | 50,000 | 939,083 | 27,704 | Nov 03, 2022, 04:28 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Oct 04, 2022 | Option Exercise | $18.78 | 50,000 | 939,078 | 27,704 | Oct 06, 2022, 04:59 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | PATRICK DEVAL L | Director | Sep 12, 2022 | Sale | $21.70 | 95,410 | 2,070,459 | 47,705 | Sep 14, 2022, 05:10 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Ceesay Abraham | President | Sep 08, 2022 | Sale | $22.84 | 38,420 | 877,321 | 19,210 | Sep 12, 2022, 04:24 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Ceesay Abraham | President | Aug 22, 2022 | Sale | $22.84 | 19,210 | 438,660 | 9,605 | Aug 24, 2022, 04:05 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH | Director | Aug 16, 2022 | Buy | $35.00 | 1,425,000 | 49,875,000 | 6,511,727 | Aug 18, 2022, 05:10 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Ceesay Abraham | President | Aug 15, 2022 | Option Exercise | $23.64 | 19,212 | 454,268 | 9,606 | Aug 17, 2022, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Aug 10, 2022 | Option Exercise | $23.57 | 110,000 | 2,592,173 | 57,704 | Aug 12, 2022, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Aug 05, 2022 | Sale | $18.00 | 40,000 | 720,000 | 22,704 | Aug 09, 2022, 09:23 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $20.63 | 20,000 | 412,500 | 12,704 | Aug 09, 2022, 09:23 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Sale | $26.59 | 20,000 | 531,701 | 10,000 | Aug 09, 2022, 09:18 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Ceesay Abraham | President | Aug 05, 2022 | Option Exercise | $22.84 | 76,848 | 1,754,824 | 38,424 | Aug 09, 2022, 08:59 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Ceesay Abraham | President | Aug 08, 2022 | Sale | $25.90 | 38,422 | 995,033 | 19,211 | Aug 09, 2022, 08:59 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Jul 20, 2022 | Option Exercise | $16.75 | 50,000 | 837,500 | 27,704 | Jul 22, 2022, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Jul 05, 2022 | Option Exercise | $16.75 | 50,000 | 837,500 | 27,704 | Jul 07, 2022, 04:06 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Jul 06, 2022 | Option Exercise | $18.00 | 2,210 | 39,780 | 3,809 | Jul 07, 2022, 04:06 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Apr 13, 2022 | Option Exercise | $19.07 | 90,000 | 1,716,592 | 46,980 | Apr 15, 2022, 04:19 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Mar 29, 2022 | Sale | $19.25 | 20,000 | 385,000 | 11,980 | Mar 31, 2022, 04:05 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Mar 16, 2022 | Sale | $16.75 | 50,000 | 837,505 | 26,980 | Mar 18, 2022, 07:56 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Mar 18, 2022 | Sale | $18.00 | 40,000 | 720,004 | 21,980 | Mar 18, 2022, 07:56 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Mar 09, 2022 | Sale | $18.42 | 60,000 | 1,105,000 | 31,980 | Mar 11, 2022, 04:08 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Mar 02, 2022 | Option Exercise | $16.75 | 50,000 | 837,500 | 26,980 | Mar 04, 2022, 04:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Feb 09, 2022 | Option Exercise | $16.75 | 50,000 | 837,500 | 26,980 | Feb 11, 2022, 06:46 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 23, 2021 | Sale | $19.25 | 11,746 | 226,138 | 7,853 | Dec 28, 2021, 04:31 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 27, 2021 | Option Exercise | $19.25 | 8,254 | 158,890 | 6,107 | Dec 28, 2021, 04:31 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 21, 2021 | Sale | $18.00 | 14,600 | 262,800 | 9,280 | Dec 23, 2021, 05:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 17, 2021 | Sale | $18.00 | 14,244 | 256,392 | 9,102 | Dec 17, 2021, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 15, 2021 | Sale | $16.76 | 50,000 | 837,948 | 26,980 | Dec 17, 2021, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Dec 16, 2021 | Sale | $18.00 | 11,156 | 200,808 | 7,558 | Dec 17, 2021, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Renger John | Chief Scientific Officer | Nov 10, 2021 | Sale | $21.68 | 110,000 | 2,384,687 | 55,000 | Nov 15, 2021, 04:18 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Aug 26, 2021 | Buy | $30.23 | 68,047 | 2,057,061 | 5,086,727 | Aug 31, 2021, 02:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Aug 24, 2021 | Buy | $27.73 | 69,761 | 1,934,472 | 4,957,293 | Aug 25, 2021, 07:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH | Director | Aug 25, 2021 | Buy | $28.57 | 61,387 | 1,753,827 | 5,018,680 | Aug 25, 2021, 07:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Aug 23, 2021 | Buy | $25.78 | 44,437 | 1,145,586 | 4,887,532 | Aug 25, 2021, 07:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH | Director | Jul 07, 2021 | Buy | $25.00 | 200,000 | 5,000,000 | 4,843,095 | Jul 09, 2021, 06:39 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Sulzberger Gabrielle | Director | Jun 17, 2021 | Buy | $13.06 | 21,084 | 275,357 | 35,354 | Jun 22, 2021, 06:31 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | MISHAN ORLY | Chief Business Officer | Jan 26, 2021 | Option Exercise | $3.50 | 38,450 | 134,575 | 38,450 | Jan 28, 2021, 07:35 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Bain Capital Fund XII, LP | 10% Owner | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Koppel Adam | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Gordon Christopher R | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:51 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | EDELMAN JOSEPH | Director | Oct 27, 2020 | Buy | $10.00 | 3,000,000 | 30,000,000 | 3,157,295 | Oct 29, 2020, 08:00 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Koppel Adam | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | BCPE Perception GP, LLC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | Gordon Christopher R | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
CERF | | Cerevel Therapeutics Holdings, Inc. | PFIZER INC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 1,200,000 | 12,000,000 | 27,349,211 | Oct 29, 2020, 05:44 PM |
ARYB | | ARYA Sciences Acquisition Corp II | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Oct 20, 2020 | Buy | $10.00 | 114,100 | 1,141,000 | 114,100 | Oct 22, 2020, 08:34 PM |
ARYB | | ARYA Sciences Acquisition Corp II | EDELMAN JOSEPH | Director | Oct 21, 2020 | Buy | $10.09 | 43,195 | 435,838 | 157,295 | Oct 22, 2020, 08:34 PM |
ARYB | | ARYA Sciences Acquisition Corp II | ARYA Sciences Holdings II | 10% Owner | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
ARYB | | ARYA Sciences Acquisition Corp II | Stone Adam Leo | Chief Executive Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
ARYB | | ARYA Sciences Acquisition Corp II | ALTMAN MICHAEL SETH | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:23 PM |